Tirzepatide, sold as Zepbound and Mounjaro, and semaglutide, under the brand names Wegovy and Ozempic, have become wildly popular for weight loss and have demonstrated other health benefits, such as heart-protective properties
This reflects a broader clinical reality: GLP-1 medications do not reset metabolism - they actively suppress appetite while they are in your system
People who are already relatively lean (under 25% body fat for men or under 32% for women) may find that GLP-1 medications produce less dramatic weight loss but still improve body composition through targeted fat reduction
It must not be administered to humans or animals outside of approved clinical trials
Studied in research involving tissue repair signaling, gastric mucosal protection, and angiogenesis pathways
Compare this to what you might find at budget tirzepatide options where cost savings sometimes come at the expense of purity or reliability